Research findings, pricing news, and vendor analysis across the peptide market.
Showing 151 to 163 of 163
There are dozens of online weight loss programs. Most aren't worth your money. We reviewed the ones that are — ranked by pricing, medications, and the support you actually get.
Read more →Brand-name Wegovy costs $1,350/month. Compounded semaglutide starts at $149/month online. Here's where to get it, what to look for, and what to avoid.
Read more →Same active ingredient, 80% cheaper. So what's the catch? An honest look at the differences between FDA-approved Ozempic and compounded semaglutide — and how to decide.
Read more →Brand Zepbound costs $1,069/month. Compounded tirzepatide starts around $249/month. But is it legit? Here's what real users report and what to look for.
Read more →Without insurance, brand-name GLP-1s cost $12,000–$16,000 per year. Here are real, legal ways to get the same medications for $149–$349/month — no insurance needed.
Read more →Compounded GLP-1s cost a fraction of brand-name Wegovy or Zepbound. But are they the same drug? An honest breakdown of 503A vs 503B pharmacies, what's identical, what's different, and how to decide.
Read more →Wegovy costs $1,350/month. Zepbound costs $1,069/month. Here's how to pay 50–80% less — through insurance navigation, manufacturer savings programs, compounding pharmacies, and telehealth platforms starting at $149/mo.
Read more →Starting Ozempic, Wegovy, or Mounjaro and wondering about drinking? Research shows GLP-1s significantly reduce alcohol cravings — but also change your tolerance in ways that matter practically.
Read more →Most people regain two-thirds of their lost weight within a year of stopping GLP-1 medications. Here's what the clinical trials show, why it happens biologically, and practical strategies to minimize regain.
Read more →Up to 70% of GLP-1 patients experience side effects — but most are manageable and temporary. This evidence-based guide covers what to expect at each phase of treatment and practical strategies for every common side effect.
Read more →New research from the Technical University of Munich and Harvard Medical School reveals that semaglutide and tirzepatide don't just promote weight loss — they appear to fundamentally reshape the body's metabolic and inflammatory pathways in ways researchers didn't fully anticipate.
Read more →New research from the University of Eastern Finland has found that semaglutide (Ozempic/Wegovy) is associated with significantly reduced rates of depression, anxiety, and substance use disorders — adding to a growing body of evidence that GLP-1 drugs do far more than cause weight loss.
Read more →The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
